SEATTLE - Know Labs, Inc. (NYSE American: KNW), a company specializing in non-invasive medical diagnostic technology, announced the completion of a financing round on Thursday, raising $1.655 million ...

Know Labs plans to file a resale registration statement for the shares underlying the convertible note and warrant within 30 days of the initial closing, aiming for effectiveness within 90 days.

Pete Conley, Know Labs’ CFO and SVP of IP, will share his perspective into why a strategically developed IP portfolio serves as the foundation for long-term value creation SEATTLE, May 23, ...

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today shared an update on its strategic partnerships with leading ...

SEATTLE, February 28, 2025--(BUSINESS WIRE)--Know Labs, Inc. ("Know Labs" or "Company") a leading innovator in Radio Frequency Dielectric Spectroscopy (RFDS) sensor technology, announced today that ...

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW) (the “Company”), a leading developer of non-invasive medical diagnostic technology, today announced that it has entered into definitive ...

SEATTLE, July 24, 2025--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW ("Know Labs" or the "Company"), a technology innovator specializing in non-invasive health monitoring solutions, today ...

Company to Drive Monetization of its Patented Platform Technology Across Diverse Industries The launch of KTL represents a pivotal milestone in Know Labs’ strategic growth plan. While the company ...

Deadline to vote (if not voting at the meeting): Internet and telephone voting facilities for stockholders of record will close at 11:59 p.m., Eastern time, on July 23, 2025. You may have received ...

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW) (the “Company”), an emerging developer of non-invasive medical diagnostic technology, today announced the pricing of a firm commitment ...

Know Labs' patented and patent-pending technology utilizes spectroscopy to identify unique molecular signatures, which has potential applications beyond glucose monitoring, including other lab-based ...